Stockreport

Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine [Yahoo! Finance]

Tempus AI, Inc. - Class A  (TEM) 
PDF partnership with Merck to fast-track the development of AI-driven precision medicine and support the pharma-maker's oncology portfolio and other therapeutic offerings. [Read more]